Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Introgen Therapeutics -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (250)	3/20/2005 12:46:20 AM
From: zeta1961	Read Replies (1) \| Respond to of 802

<Short Selling INGN> Ya' a INGN short seller dah'ling ..My gut tells me we will be hearing of a 'something' related to SG Cowen or Rodman and Renshaw in the future..Their absence/silence on the recent CC was quite present/loud..that failed secondary last year led to them hiring Morrow to audit the trading..Nance has too big a stake and resources, and pride to let that go un-checked..I'm also sure Cowen/R&R were blind sided by the European PIPES..one of the posters on YMB remarked in relation to INGN's pipe(mda7)that Nance is proving he's good at the PIPELINE business<g> I also think that FUS1 is a sleeper.. This field just needs one success..the landscape will be transformed.. Zeta